Estimating costs and benefits of CTL escape mutations in SIV/HIV infection

PLoS Computational Biology

Volumn 2, Issue 3, 2006, Pages 182-187

  Ganusov, Vitaly V ^a,b   De Boer, Rob J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b INSTITUTE OF BIOPHYSICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST ESTIMATING; PARAMETER ESTIMATION;

% REDUCTIONS; CONDITION; COST AND BENEFITS; CYTOTOXIC T LYMPHOCYTES; DE BOERS; FITNESS COSTS; HIV INFECTION; IN-VIVO; VIRAL FITNESS; VIRUS-INFECTED CELLS;

VIRUSES;

EPITOPE;

ALGORITHM; ARTICLE; CD8+ T LYMPHOCYTE; COST BENEFIT ANALYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MATHEMATICAL MODEL; MUTATION; PREDICTION; REVERTANT; SIMIAN IMMUNODEFICIENCY VIRUS; THEORETICAL MODEL; VIROGENESIS; VIRUS INFECTION; VIRUS REPLICATION; WILD TYPE; ANIMAL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HIV; HIV INFECTIONS; HUMANS; MUTATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33645772992     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0020024     Document Type: Article

References (31)

1. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, et al. (1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
2. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
3. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, et al. (1999) HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752.
4. Trachtenberg E, Korber B, Sollars C, Kepler T, Hraber P, et al. (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9: 928-935.
5. Carrington M, O'Brien S (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54: 535-551.
6. Kiepiela P, Leslie A, Honeyborne I, Ramduth D, Thobakgale C, et al. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
7. Goulder P, Watkins D (2004) HIV and SIV CTL escape: Implications for vaccine design. Nat Rev Immunol 4: 630-640.
8. Kent S, Fernandez C, Dale C, Davenport M (2005) Reversion of immune escape HIV variants upon transmission: Insights into effective viral immunity. Trends Microbiol 13: 243-246.
9. Allen T, Altfeld M, Yu X, O'Sullivan K, Lichterfeld M, et al. (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78: 7069-7078.
10. Draenert R, Le Gall S, Pfafferott K, Leslie A, Chetty P, et al. (2004) Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection. J Exp Med 199: 905-915.
11. Fernandez C, Stratov I, De Rose R, Walsh K, Dale C, et al. (2005) Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 79: 5721-5731.
12. Asquith B, Edwards C, Lipsitch M, McLean A (2006) Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biology. 4 (4): e90.
13. Holland J, de la Torre J, Clarke D, Duarte E (1991) Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J Virol 65: 2960-2967.
14. Maree AF, Keulen W, Boucher CA, De Boer RJ (2000) Estimating relative fitness in viral competition experiments. J Virol 74: 11067-11072.
15. Mattapallil J, Douek D, Hill B, Nishimura Y, Martin M, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
16. Li Q, Duan L, Estes J, Ma Z, Rourke T, et al. (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434: 1148-1152.
17. Bonhoerrer S, Barbour A, De Boer R (2002) Procedures for reliable estimation of viral fitness from time-series data. Proc R Soc Lond B Biol Sci 269: 1887-1893.
18. Little S, McLean A, Spina C, Richman D, Havlir D (1999) Viral dynamics of acute HIV-1 infection. J Exp Med 190: 841-850.
19. Nowak M, Lloyd A, Vasquez G, Wiltrout T, Wahl L, et al. (1997) Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol 71: 7518-7525.
20. Bonhoeffer S, Funk G, Gunthard H, Fischer M, Muller V (2003) Glancing behind virus load variation in HIV-1 infection. Trends Microbiol 11: 499-504.
21. Davenport M, Ribeiro R, Perelson A (2004) Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J Virol 78: 10096-10103.
22. Kobayashi M, Igarashi H, Takeda A, Kato M, Matano T (2005) Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation. J Virol 79: 11529-11532.
23. Barouch D, Powers J, Truitt D, Kishko M, Arthur J, et al. (2005) Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol 6: 247-252.
24. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, et al. (2001) Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27 -restricted cytotoxic T lymphocyte responses. J Exp Med 193: 375-386.
25. Peyerl F, Barouch D, Yeh W, Bazick H, Kunstman J, et al. (2003) Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope. J Virol 77: 12572-12578.
26. Friedrich T, Frye C, Yant L, O'Connor D, Kriewaldt N, et al. (2004) Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J Virol 78: 2581-2585.
27. Yang O, Church J, Kitchen C, Kilpatrick R, Ali A, et al. (2005) Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins. J Virol 79: 15368-15375.
28. Matano T, Kobayashi M, Igarashi H, Takeda A, Nakamura H, et al. (2004) Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J Exp Med 199: 1709-1718.
29. Perelson A, Neumann A, Markowitz M, Leonard J, Ho D (1996) HIV-1 dynamics in vivo: Virion clearance rate, infected cell lifespan, and viral generation time. Science 271: 1582-1586.
30. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, et al. (1999) Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782-1785.
31. Zhang L, Dailey PJ, He T, Gettie A, Bonhoerrer S, et al. (1999) Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J Virol 73: 855-860.